The Bicêtre Hospital is located in Le Kremlin-Bicêtre, a commune in the southern suburbs of Paris, France. It lies 4.5 km from the center of Paris. The Bicêtre Hospital was originally planned as a military hospital, with construction begun in 1634.

There are 301 beds in Hopital Bicëtre.

During the past decade, Hopital Bicëtre conducted 281 clinical trials. In the 10-year time frame, 281 clinical trials started and 39 clinical trials were completed, i.e. on average, 13.9% percent of trials that started reached the finish line to date. In the past 5 years, 145 clinical trials started and 29 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Bicëtre" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 74 trials, followed by "ANRS, Emerging Infectious Diseases" with 13 trials sponsored, "Actelion" with 10 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 10 trials sponsored and "Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives" with 10 trials sponsored. Other sponsors include 302 different institutions and companies that sponsored additional 147 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bicëtre" #1 collaborator was "Ministry of Health, France" with 13 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 9 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 7 trials as a collaborator, "Bicetre Hospital" with 5 trials as a collaborator and "Gilead Sciences" with 4 trials as a collaborator. Other collaborators include 237 different institutions and companies that were collaborators in the rest 203 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Bicëtre" are "Pulmonary Arterial Hypertension" (16 trials), "Acromegaly" (13 trials), "HIV Infections" (13 trials), "Crohn's Disease" (11 trials) and "Rheumatoid Arthritis" (9 trials). Many other conditions were trialed in "Hopital Bicëtre" in a lesser frequency.

Most popular intervention types in "Hopital Bicëtre" are "Drug" (201 trials), "Other" (79 trials), "Device" (57 trials), "Procedure" (39 trials) and "Biological" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Baricitinib" (5 trials), "Macitentan" (5 trials), "placebo" (5 trials) and "Emicizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bicëtre" are 378 trials for "All" genders, 32 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 139 active trials in "Hopital Bicëtre". 14 are not yet recruiting, 98 are recruiting, 24 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 210 completed trials in Hopital Bicëtre, undefined suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bicëtre, 11 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 100 trials that are defined as “Not Applicable".